Out of Site: Decentralized Clinical Trials and Their Effect on Sponsors and Patients
The effects of the recent healthcare pandemic, as well as further expansion into digital therapeutics and complex clinical trials, has created the need to update the current face-to-face, on-site testing and treatment structure. Revising traditional trial logistics and operations though a decentralization strategy has the potential to keep these research studies on-track. Decentralized clinical trials offer an innovative approach to traditional research methods, leveraging digital technology and social media to facilitate site-less trials and patient-centric protocols. Trial sponsors and patients alike reap the rewards of decentralization, from improved efficiency and retention to stronger communication and adherence to treatment.
This webinar will highlight the benefits of a decentralized structure for all trial stakeholders, exploring virtual and patient-centric strategies for clinical trials, as well as the post-market advantages of homecare treatments and pharmacy solutions.
Webinar Agenda Includes:
- Providing better solutions and outcomes through decentralized and sometimes site-less trials
- Leveraging both traditional and innovative protocols to facilitate hybrid trials
- Managing challenges and obstacles to integrating decentralization into clinical trials
Jimmy El Hokayem Head, Neurology and Regenerative Medicine Center of Excellence at Biorasi
Marc Gas Senior Manager, Program Development at Biorasi